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Abstract
microRNAs are an extensive class of non-coding genes that regulate gene expression through post-
transcriptional repression. These small RNAs are evolutionarily conserved and are likely to be a basic
mechanism of gene regulation present within most eukaryotic organisms. Over 100 viral miRNAs
have been identified to date through a combination of bioinformatics and cloning studies. In this
review we discuss the use of bioinformatics for the identification of HCMV miRNAs and also for
the discovery of potential target transcripts. Such studies will enable us to define the functional role
of viral miRNAs and gain a better understanding of viral gene regulation.
The discovery of small regulatory RNA molecules known as microRNAs (miRNAs) is
undoubtedly one of the most important recent findings in biological research. Initially
identified in C. elegans, the regulation of the developmental gene lin-14 by a small RNA
molecule named lin-4 was first thought to be an unusual example of gene expression control
(Lee et al., 1993; Wightman et al., 1993). However additional investigations revealed that the
expression of miRNAs was more common than initially believed. It is now thought that
regulation of gene expression by miRNAs is a mechanism common to all metazoan organisms
(Bartel, 2004; Pfeffer et al., 2005; Pfeffer et al., 2004). In addition, a number of studies by
multiple groups have clearly shown that mammalian DNA viruses, especially of the
herpesvirus family, have evolved their own miRNA genes (Burnside et al., 2006; Cai et al.,
2005; Cai et al., 2006; Cui et al., 2006; Dunn et al., 2005; Grey et al., 2005; Gupta et al.,
2006; Lu and Cullen, 2004; Pfeffer et al., 2005; Pfeffer et al., 2004; Samols et al., 2005; Sano
et al., 2006; Sullivan et al., 2005; Yao et al., 2007). In this review, the identification and
characterization of miRNAs expressed by human cytomegalovirus, and the genes they target,
will be discussed.
miRNAs are generated from single stranded RNA precursors, called pri-miRNAs, that are
expressed in the nucleus (Lee et al., 2002). These RNA transcripts form stem-loop structures
of around 70 bases in length that are cleaved from the pri-miRNA by the nuclear RNaseIII
endonuclease enzyme Drosha (Lee et al., 2003). The resulting stem-loop structure, termed pre-
miRNA, is transported into the cytoplasm by exportin 5 (Lund et al., 2004; Yi et al., 2003)
where it is recognized and processed by the cytoplasmic RNaseIII endonuclease, Dicer
(Bernstein et al., 2001; Grishok et al., 2001; Hutvagner et al., 2001; Ketting et al., 2001),
producing a single stranded RNA molecule of around 22 bases in length. The RNA fragment
from the corresponding arm of the stem loop, known as the miRNA*, is thought to be rapidly
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degraded (Lim et al., 2003). Following processing by Dicer the miRNA forms a
ribonucleocomplex known as the RNA induced silencing complex or RISC (Hammond et al.,
2000; Hutvagner and Zamore, 2002; Mourelatos et al., 2002) that uses the associated miRNA
as a guide sequence to identify target mRNAs. This leads to post-transcriptional regulation by
two distinct mechanisms, depending on the level of homology of the miRNA with the mRNA
target. Perfect or near perfect homology with the target mRNA leads to RISC mediated
cleavage, (Elbashir et al., 2001a; Elbashir et al., 2001b) whereas less stringent homology
between the miRNA and sites within the 3’ untranslated region (UTR) of the target leads to
translational repression (Wightman et al., 1993; Zeng et al., 2002). A second class of small
RNAs, small interfering RNAs (siRNAs), are generated from long double stranded RNAs,
following direct processing by Dicer in the cytoplasm (Bernstein et al., 2001; Elbashir et al.,
2001a). It is currently thought that the targeting mechanisms of siRNAs and miRNAs are
similar, with both able to direct cleavage or translational repression of the target RNA through
the actions of the RISC (Doench et al., 2003; Hutvagner and Zamore, 2002; Zeng et al.,
2002).
In plants, cleavage of target transcripts by small RNAs is a common mechanism of post-
transcriptional regulation (Rhoades et al., 2002). The perfect, or near perfect, sequence
homology associated with guiding cleavage of the target mRNA has made the identification
of many RNAi targets in plants a relatively straight forward process. However, in animals,
cleavage of the target mRNA rarely seems to occur (Yekta et al., 2004), suggesting that post-
transcriptional regulation by translational repression is likely to be a more common mechanism.
The lack of direct homology of animal miRNAs to their target sequences makes it considerably
harder to determine their function (Enright et al., 2003; John et al., 2004). However the miRNA
targets that have been identified in animals suggests that post-transcriptional regulation by
RNAi is critical in a diverse array of biological functions, particularly in developmental
processes, with their disruption leading to acute abnormalities (Brennecke et al., 2003;
Johnston and Hobert, 2003; Lee et al., 1993; Wightman et al., 1993; Yang et al., 2004; Yekta
et al., 2004).
The initial discovery of miRNAs was achieved using forward genetic studies that mapped
specific genomic regions responsible for observed developmental phenotypes (Lee et al.,
1993). Subsequent strategies have utilized extensive cloning and sequencing of small RNAs
as well as bioinformatics approaches.
Identification of HCMV encoded miRNAs
To identify miRNAs encoded by human cytomegalovirus we used a comparative
bioinformatics method. A computer algorithm called Stem-loop Finder (SLF) (Combimatrix)
was used to predict potential RNA transcripts from the HCMV genome that could form stem-
loop secondary structures. To further refine this method the predicted stem loop sequences
were compared to the closely related chimpanzee cytomegalovirus genome as we predicted
that genuine miRNA sequences would demonstrate evolutionary conservation. Additional
analysis of the conserved stem loops was performed using an online algorithm called miRscan,
that compares two conserved sequences and determines the likelihood that they encode an
miRNA based on a number of structural aspects such as the ability to form a stem-loop,
symmetry of bulge loops and conservation of the predicted miRNA sequence (Lim et al.,
2003). This analysis led to the identification of 13 candidate miRNA sequences encoded
throughout the viral genome. Expression of five of the 13 miRNAs, miR-UL36-1, miR-
UL70-1, miR-US4-1, miR-US5-1 and miR-US5-2, was confirmed through northern blot
analysis (Grey et al., 2005). Following this study, and those of two other groups, a total of 11
miRNAs have been identified, including miR-UL22A-1, miR-UL112-1, miR-UL148D-1,
Grey and Nelson Page 2













miR-US25-1, US25-2, US33-1 and the five previously described (Dunn et al., 2005; Pfeffer
et al., 2005).
Unlike alpha and gamma herpes viruses, where miRNA genes are clustered within regions of
the genome associated with latent gene expression, miRNAs of HCMV are encoded throughout
the genome (figure 1). Consistent with mammalian species many of the HCMV miRNAs are
encoded within intergenic regions, and in at least one case, miR-UL36-1, encoded within the
spliced intron of a coding gene. A number of the miRNAs are however encoded within open
reading frames. miR-UL112-1 is encoded directly antisense to the viral uracil DNA
glycosylase, a situation that could theoretically lead to the cleavage of the transcript and
negative regulation of the gene. Somewhat surprisingly, however, studies in our lab have shown
that the UL114 transcript is resistant to cleavage by miR-UL112-1, despite high levels of both
RNAs being present during acute infection (unpublished observation). miR-UL112-1 is
capable of negatively regulating an antisense sequence such as that within the UL114 transcript
when placed within the 3’UTR of a reporter gene, suggesting that the UL114 transcript is
resistant to the effects of miR-UL112-1, possibly achieved through protective secondary
structure introduced by the sequence flanking the potential cleavage site.
Functional role of HCMV miRNAs
Validated target transcripts and regulatory functions for the vast majority of viral miRNAs
remain unknown. Two likely scenarios for viral miRNA function include targeting of cellular
gene expression to induce a more favorable environment for the virus, or the regulation of viral
genes to establish precise temporal or tissue specific regulation of viral gene expression. Two
recent studies would suggest that both scenarios occur and that a single viral miRNA is capable
of regulating both cellular and viral transcripts (Grey et al., 2007; Stern-Ginossar et al.,
2007).
In a study designed to identify potential viral targets we used a comparative bioinformatic
approach similar to that used to identify miRNA genes in our previous study (Grey et al.,
2007). As the miRNAs encoded by HCMV are well conserved in CCMV we predicted that
genuine target sequences within the viral genomes would also be conserved. Using an online
algorithm called RNAhybrid we predicted potential target sites within 3’UTR sequences within
the HCMV genome. As transcripts from HCMV have not been fully mapped a putative data
base of predicted 3’UTR sequences for HCMV were initially created by selecting sequence
from the end of each annotated open reading frame to the first canonical poly adenylation signal
(AATAAA). The analysis was repeated for the CCMV genome and the results compared to
identify transcripts that contained target sites within the corresponding 3’UTRs of HCMV and
CCMV. The number of predicted target transcripts identified using this approached ranged
from 0 – miR-UL22A-1 to 29 – miR-UL25-2.
Of particular interest were the results for the miRNA miR-UL112-1. A total of 14 transcripts
were found to contain potential target sequences, including a cluster of three targets within the
major immediate early region of the virus. The major immediate early region of HCMV is
known to express a number of regulatory proteins crucial for the efficient replication of the
virus and coordination of viral gene expression. The most abundant of these proteins are the
major trans-activators IE72 and IE86, which are expressed from 5 exons within the major
immediate early region (figure 2) (Stenberg et al., 1989;Stenberg et al., 1984;Stenberg et al.,
1985). Both proteins are thought to be important in promoting early and late viral transcription,
although only IE86 is essential for virus replication (Greaves and Mocarski, 1998;Mocarski et
al., 1996;Stenberg et al., 1990;White et al., 2004;White et al., 2007). Disruption of IE72
expression does result in a significant attenuation of viral replication following low multiplicity
infections (Mocarski et al., 1996). A single target site was identified within the 3’UTR of IE72
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with two further target sequences within the 3’UTRs of down stream open reading frames
UL120 and UL121. Intriguingly, the corresponding site identified downstream of IE72 in
CCMV maintained less homology to miR-UL112-1 than the equivalent site in HCMV, and
would presumably form a less effective binding site. However, a second site was identified
further upstream that was not found in the HCMV counterpart, suggesting that CCMV has
evolved two less effective binding sites in comparison to the more homologous single site
found in HCMV. These sites, along with a predicted site within the 3’UTR of UL112/113
demonstrated effective regulation of luciferase expression when cloned down stream of the
reporter gene, following expression of miR-UL112-1. Expression of miR-UL112-1 also
resulted in a decrease in IE72 protein expression following co-transfection with a construct
containing the major immediate early region of HCMV and also following infection with the
virus. These results demonstrate that the HCMV-encoded miRNA miR-UL112-1 is able to
specifically regulate the expression of one of the major immediate early trans-activators of the
virus. Given that IE72 is an important transactivator and required for efficient viral replication
we hypothesized that expression of miR-UL112-1 early in infection may result in attenuation
of acute replication. To test this theory we transfected cells with a synthetic miR-UL112-1
RNA duplex then infected cells with HCMV and measured DNA replication of the virus.
Compared with cells transfected with a control miRNA, HCMV DNA replication was inhibited
up to 5 fold indicating that expression of miR-UL112-1 has the potential to attenuate acute
replication of HCMV (figure 3).
In addition to regulation of viral genes, a recent report demonstrates that miR-UL112-1 also
targets a cellular gene involved in host innate immune responses to viral infection (Stern-
Ginossar et al., 2007). Using a target prediction algorithm based on the identification of
repeated target sites within cellular 3’UTR sequences, Stern-Ginossar et al, identified a
potential target sequence for miR-UL112-1 within the 3’UTR of MHC class-I related chain B
(MICB). MICB is a cellular ligand for the receptor NKG2D on Natural Killer cells that is
expressed in response to viral infections. Activation of NK cells through association of MICB
with NKG2D can lead to cell killing. Blocking this interaction would therefore be of obvious
benefit to the virus as emphasized by the demonstration that deletion of miR-UL112-1 led to
an increased susceptibility to NK killing. Interestingly, HCMV also encodes a protein, UL16,
which was previously shown to inhibit MICB signaling by intracellular sequestration,
suggesting a level of redundancy in targeting of MICB (Dunn et al., 2003).
Physiological relevance of miR-UL112-1 targeting of IE72 and MICB
These studies have clearly demonstrated that a viral miRNA is able to regulate both cellular
and viral genes. However it is still a question as to why the virus would target these genes by
miRNA expression. Targeting of MICB seems relatively understandable, although the
necessity to target MICB by miRNA when the virus expresses a protein for the same function
is less clear. Targeting of a viral gene required for efficient replication also seems
counterintuitive. One possible explanation for both of these anomalies is that miR-UL112-1
may be specifically required for the establishment or maintenance of latent or persistent
infection rather than during acute replication of the virus. Cytomegaloviruses establish life
long infections of their hosts, during which time the virus maintains a restricted replication
profile either as a persistent infection, with production of low levels of virus, or a true latent
infection, in which virus is only produced following a reactivation stimulus. To achieve this,
the virus must employ strict regulation of viral gene expression and mechanisms to evade the
host immune system. The non-immunogenic nature of miRNAs and their ability to target
multiple genes, both host and viral, would make them ideal agents of gene regulation during
latent or persistent infection. Expression of miR-UL112-1 may allow the virus to restrict the
expression of immunogenic viral genes involved in acute replication, while at the same time
modulating the host immune response to protect the infected cell from NK induced cell death.
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The major immediate early genes, including IE72, have been suggested to play pivotal roles
in controlling latency and reactivation as both genes are important in driving the expression of
early and late genes required for acute replication of the virus. Furthermore expression of the
functional homologues of IE72 and IE86 in latent MCMV infections of mouse lungs have
suggested that the regulated expression of these genes may represent a significant control step
in the triggering of reactivation (Simon et al., 2006). Therefore regulation of IE72 would be
an effective switch mechanism and as demonstrated by our studies showing miR-UL112-1 has
the capacity to restrict acute replication.
The redundancy observed in the targeting of MICB may also be a phenomenon of HCMV
latency. The expression of UL16 protein may be a more robust mechanism of targeting MICB,
required during acute replication of the virus, when the host immune response is likely to be
more vigorous. However targeting of MICB by miR-UL112-1 may be more suitable for long
term regulation during persistent or latent infection where it is likely the less robust nature of
miRNA regulation would be adequate, while avoiding the production of potentially
immunogenic viral proteins.
The clinical relevance of these findings is two fold. There are currently small molecule
inhibitors of miRNAs that are highly effective and specific. Targeting of miR-UL112-1 using
such inhibitors could drive the virus towards acute replication, while at the same time disrupting
the inhibition of MICB expression, resulting in possible immune clearance of the virus. This
has potential risks of pathological effects caused by acutely replicating HCMV, especially in
immunocompromised patients – which are also the patients most in need of antiviral therapy.
A second option would be to mimic the expression of miR-UL112-1 using synthetic miRNAs
in an attempt to attenuate acute replication of the virus. Unlike many antivirals that artificially
block viral processes, delivery of endogenous viral miRNAs could exploit the virus’s own
mechanisms to subdue replication. Not only might this approach be effective, but it could also
be less prone to the problems of viral escape and resistance as the virus has evolved to maintain
these mechanisms. Potential drawbacks include off target effects of delivering high levels of
synthetic miRNAs and also the risk of immune suppression due to regulation of MICB.
Given the potential for the regulation of multiple viral and cellular genes it is likely that
additional studies will demonstrate important regulatory roles for each of the HCMV miRNAs.
Although challenging, it will be of particular interest to investigate the potential role of HCMV
miRNAs in the establishment and maintenance of persistent and latent infections and the
possible development of therapeutic agents based on the function of viral miRNAs.
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Genomic map of HCMV miRNAs. Known HCMV miRNAs are represented by black arrows
indicating genomic position and orientation in relation to predicted and known open reading
frames.
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Genomic position of miR-UL112-1 targets sites within the major immediate early region. The
major immediate early region showing IE72 and IE86 transcripts resulting from alternative
splicing are shown as well as splicing to down stream exons UL120/UL121. Position of miR-
UL112-1 target sites in 3’UTR region of IE72 and UL120/UL121 indicated by red boxes (Grey
et al., 2007).
Grey and Nelson Page 10














DNA was isolated from infected cells at indicated time points and viral DNA levels determined
by real time PCR and corrected against beta-actin copies. Transfection of miR-UL112-1 (syn
miR-UL112-1) results in consistently lower levels of HCMV DNA at later time points
compared to cells transfected with randomized control miRNA (syn negative) (Grey et al.,
2007).
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